BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26826771)

  • 1. [Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis].
    Di Marco J; De Broglie C; Manceau P; Weglinski L; Le Breton F; Verrollet D; Amarenco G
    Prog Urol; 2016 Mar; 26(4):226-9. PubMed ID: 26826771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospective evaluation of mouth and eye dryness induced by antimuscarinic drugs used for neurogenic overactive bladder in 35 patients with multiple sclerosis].
    Weglinski L; Manceau P; Thomas-Pohl M; Le Breton F; Amarenco G
    Prog Urol; 2017 Mar; 27(4):253-260. PubMed ID: 27955902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
    Geller EJ; Crane AK; Wells EC; Robinson BL; Jannelli ML; Khandelwal CM; Connolly A; Parnell BA; Matthews CA; Dumond JB; Busby-Whitehead J
    Clin Drug Investig; 2012 Oct; 32(10):697-705. PubMed ID: 22873491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Relationship Between Overactive Bladder and Sexual Dysfunction in Women With Multiple Sclerosis?
    Le Breton F; Chesnel C; Lagnau P; Haddad R; Lacroix P; Miget G; Amarenco G; Hentzen C
    J Sex Med; 2022 May; 19(5):729-737. PubMed ID: 35370100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Female sexual dysfunction and multiple sclerosis: A case-control study].
    Masmoudi R; Aissi M; Halouani N; Fathallah S; Louribi I; Aloulou J; Amami O; Frih M
    Prog Urol; 2018 Sep; 28(11):530-535. PubMed ID: 30076093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study.
    Cakir SS; Degirmentepe RB; Atalay HA; Canat HL; Ozbir S; Culha MG; Polat EC; Otunctemur A
    Int Urol Nephrol; 2019 Jan; 51(1):27-32. PubMed ID: 30448887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Description of a clinical typology specific to men whose urinary symptoms require anticholinergic treatment].
    Cornu JN; Descazeaud A; Chartier-Kastler E; Bourouina R
    Prog Urol; 2017 Sep; 27(10):551-558. PubMed ID: 28687156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly].
    Kerdraon J; Robain G; Jeandel C; Mongiat Artus P; Gamé X; Fatton B; Scheiber-Nogueira MC; Vetel JM; Mares P; Petit AC; Amarenco G;
    Prog Urol; 2014 Sep; 24(11):672-81. PubMed ID: 25214448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence with first line anticholinergic medication in treatment-naïve overactive bladder patients.
    Krhut J; Gärtner M; Petzel M; Sykora R; Nemec D; Tvrdik J; Skoupa J
    Scand J Urol; 2014 Feb; 48(1):79-83. PubMed ID: 23870042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder symptoms in multiple sclerosis: a review of pathophysiology and management.
    Nicholas R; Young C; Friede T
    Expert Opin Drug Saf; 2010 Nov; 9(6):905-15. PubMed ID: 20569078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of treatment of overactive bladder with anticholinergics on sexual function.
    Jha S
    Arch Gynecol Obstet; 2016 Feb; 293(2):403-6. PubMed ID: 26223187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder.
    Chancellor MB; Migliaccio-Walle K; Bramley TJ; Chaudhari SL; Corbell C; Globe D
    Clin Ther; 2013 Nov; 35(11):1744-51. PubMed ID: 24091072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of sexual function in women with overactive bladder syndrome.
    Sen I; Onaran M; Tan MO; Acar C; Camtosun A; Sozen S; Bozkirli I
    Urol Int; 2007; 78(2):112-5. PubMed ID: 17293648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.
    Ju R; Garrett J; Wu JM
    Int Urogynecol J; 2014 Apr; 25(4):479-84. PubMed ID: 24158462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolterodine immediate release improves sexual function in women with overactive bladder.
    Hajebrahimi S; Azaripour A; Sadeghi-Bazargani H
    J Sex Med; 2008 Dec; 5(12):2880-5. PubMed ID: 18785896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticholinergic drugs in overactive bladder].
    Muhlstein J; Deval B
    Gynecol Obstet Fertil; 2008 Jan; 36(1):90-6. PubMed ID: 18178506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sympathetic skin response and multiple sclerosis: descriptive and prospective study, and association with neuroperineal disorders].
    Thomas-Pohl M; Weglinski L; Salga M; Blum C; Manceau P; Amarenco G
    Prog Urol; 2014 Sep; 24(11):691-6. PubMed ID: 25214450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.
    Chancellor MB; de Miguel F
    Geriatrics; 2007 May; 62(5):15-24. PubMed ID: 17489643
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.